Avacopan is possibly associated with the improvement of ANCA-associated vasculitis activity without decreasing ANCA titres: a four-case series.

MLA

Abe, Yoshiyuki, et al. “Avacopan Is Possibly Associated with the Improvement of ANCA-Associated Vasculitis Activity without Decreasing ANCA Titres: A Four-Case Series.” Rheumatology, vol. 62, no. 11, Nov. 2023, pp. e317–18. EBSCOhost, https://doi.org/10.1093/rheumatology/kead191.

APA

Abe, Y., Minowa, K., Kogami, M., Ando, T., Makiyama, A., Yamaji, K., & Tamura, N. (2023). Avacopan is possibly associated with the improvement of ANCA-associated vasculitis activity without decreasing ANCA titres: a four-case series. Rheumatology, 62(11), e317–e318. https://doi.org/10.1093/rheumatology/kead191

Chicago

Abe, Yoshiyuki, Kentaro Minowa, Masahiro Kogami, Taiki Ando, Ayako Makiyama, Ken Yamaji, and Naoto Tamura. 2023. “Avacopan Is Possibly Associated with the Improvement of ANCA-Associated Vasculitis Activity without Decreasing ANCA Titres: A Four-Case Series.” Rheumatology 62 (11): e317–18. doi:10.1093/rheumatology/kead191.